| 262938 |
NEURO-ONCOLOGY |
RARE-40. BING-NEEL SYNDROME: DIAGNOSTIC & THERAPEUTIC ISSUES |
2016-11-01 |
10.1093/neuonc/now212.703 |
Cher Lawrence, Griffiths Jim |
| 262937 |
NEURO-ONCOLOGY |
NIMG-65. IN VIVO DETECTION OF 2-HYDROXYGLUTARATE IN LOW-GRADE IDH-MUTANT GLIOMAS WITH STABLE DISEASE |
2016-11-01 |
10.1093/neuonc/now212.576 |
Li Yan, Lupo Janine, Chang Susan, Nelson Sarah |
| 262936 |
ENERGY PROCEDIA |
Geomechanical Consequences of Large-scale Fluid Storage in the Utsira Formation in the North Sea |
2016-11-01 |
10.1016/j.egypro.2016.10.056 |
Wangen Magnus, Gasda Sarah, Bjørnarå Tore |
| 262935 |
NEURO-ONCOLOGY |
ACTR-06. THE TOCA 7 STUDY: PHASE 1B STUDY OF TOCA 511, A LIVE GAMMA RETROVIRUS, AND TOCA FC, AN EXTENDED-RELEASE FORMULATION OF 5-FLUOROCYTOSINE COMBINED WITH STANDARD OF CARE IN NEWLY DIAGNOSED HIGH GRADE GLIOMA (NCT02598011) |
2016-11-01 |
10.1093/neuonc/now212.005 |
Vogelbaum Michael, Lassman Andrew, Lee Ian, Liau Linda, Sonabend Adam, Walbert Tobias, Yang Liqiang, Das Asha, Cloughesy Timothy |
| 262934 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold |
2016-11-01 |
10.2147/dddt.s118116 |
Rudrapal Mithun, Chetia Diapk |
| 262933 |
BMJ OPEN |
Is Olympic inspiration associated with fitness and physical activity in English schoolchildren? A repeated cross-sectional comparison before and 18 months after London 2012 |
2016-11-01 |
10.1136/bmjopen-2016-011670 |
Sandercock Gavin R H, Beedie Chris, Mann Steve |
| 262932 |
ENERGY PROCEDIA |
Improvement of Boiler's Efficiency Using Heat Recovery and Automatic Combustion Control System |
2016-11-01 |
10.1016/j.egypro.2016.10.164 |
Suntivarakorn Ratchaphon, Treedet Wasakorn |
| 262931 |
ENDOCRINE-RELATED CANCER |
WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of ‘clock’ genes on prostate cancer |
2016-11-01 |
10.1530/erc-16-0366 |
Kiss Zsofia, Ghosh Paramita M |
| 262930 |
NEURO-ONCOLOGY |
NIMG-06. DOES PERSONALIZING TUMOR TREATING FIELDS(TTFIELDS) WITH NOVOTAL IN GLIOBLASTOMA TREATMENT PLANNING MAKE A DIFFERENCE? INSIGHTS FROM ELECTRIC FIELD SIMULATION STUDIES |
2016-11-01 |
10.1093/neuonc/now212.518 |
Chaudhry Aafia, Bomzon Ze’ev, Hershkovich Hadas Sara, Garcia-Carracedo Dario, Wenger Cornelia, Weinberg Uri, Palti Yoram |
| 262929 |
NEURO-ONCOLOGY |
STMC-03. REPOSITIONING CHLORPROMAZINE AGAINST CHEMORESISTANT GLIOMA THROUGH THE INHIBITION OF CYTOCHROME C OXIDASE |
2016-11-01 |
10.1093/neuonc/now212.767 |
Griguer Corinne E., Oliva Claudia |
